Susan Fong

Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.

Abran Q. Costales, S. Ramurthy, S. Subramanian, 2008, Journal of medicinal chemistry.

Inhibition of prenylated KRAS in a lipid environment

Charles A. Wartchow, W. Jahnke, E. Fang, 2017, PloS one.

A VP2/3-derived peptide exhibits potent antiviral activity against BK and JC polyomaviruses by targeting a novel VP1 binding site

Charles A. Wartchow, D. Bussiere, E. Ornelas, 2019, bioRxiv.

Design, structure-activity relationship, and in vivo characterization of the development candidate NVP-HSP990.

Kristin M. Brinner, N. Pryer, T. Hendrickson, 2014, Journal of medicinal chemistry.

Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism

Guoying Yu, B. Weisburd, C. Arias, 2015, eLife.

A polyomavirus peptide binds to the capsid VP1 pore and has potent antiviral activity against BK and JC polyomaviruses

Charles A. Wartchow, D. Bussiere, E. Ornelas, 2020, eLife.

Biased Complement Diversity Selection for Effective Exploration of Chemical Space in Hit-Finding Campaigns

Johanna M. Jansen, Charles A. Wartchow, Gianfranco De Pascale, 2019, J. Chem. Inf. Model..

Abstract 1142: Discovery of FMC-376 a novel orally bioavailable inhibitor of activated KRASG12C

Johannes C. Hermann, R. Neve, R. Everley, 2023, Cancer Research.